Clinical Trial Update: Study of NM8074 in Adult C3 Glomerulopathy Patients [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 1/2 study of NM8074 for adult patients with C3 glomerulopathy, noting that the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• C3 Glomerulopathy

Drugs mentioned

• NM8074

Snippet

Sponsor: NovelMed Therapeutics | Conditions: C3 Glomerulopathy | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING